E
DBV Technologies S.A. DBVT
$13.97 -$0.07-0.50% NASDAQ
Recommendation
Prev Close
$14.04
Volume
123,254
Avg Vol (90D)
76,928
Market Cap
$495.15M
Dividend & Yield
--
52-Week Range
$2.20 - $18.00
P/E (TTM)
--
EPS (TTM)
-$1.05
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
3 Biopharmaceutical Stocks Bucking the Sell-Off
4/10/2025 - MarketBeat
DBV Technologies (NASDAQ:DBVT) Stock Price Crosses Above Fifty Day Moving Average - Should You Sell?
11/7/2025 - Ticker Report
DBV Technologies S.A. (NASDAQ:DBVT) Given Average Rating of "Hold" by Brokerages
11/6/2025 - Ticker Report
DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
11/4/2025 - GuruFocus
DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
11/4/2025 - Globe Newswire
DBV Technologies appoints Kevin Trapp as chief commercial officer
11/3/2025 - The Fly
DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer
11/3/2025 - GuruFocus
DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer
11/3/2025 - Globe Newswire
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025
11/3/2025 - Globe Newswire
HC Wainwright Has Optimistic Outlook of DBVT FY2025 Earnings
11/1/2025 - MarketBeat
Is DBV Technologies (DBVT) Stock Outpacing Its Medical Peers This Year?
10/31/2025 - Zacks Investment Research
DBV Technologies S.A. (NASDAQ:DBVT) Receives Consensus Rating of "Hold" from Analysts
10/31/2025 - MarketBeat
DBV Technologies S.A (DBVT, $14.09) Stochastic Oscillator left the oversold zone on October 30, 2025
10/31/2025 - Tickeron - Stocks
DBV Technologies S.A (DBVT, $14.09) price may climb as it broke lower Bollinger Band on Oct 30, 2025
10/31/2025 - Tickeron - Stocks
Kepler Capital Reaffirms Their Buy Rating on DBV Technologies (0QAJ)
10/31/2025 - TipRanks Financial Blog
DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors
10/30/2025 - GuruFocus
DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors
10/30/2025 - Globe Newswire
DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting
10/30/2025 - GuruFocus
DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting
10/30/2025 - Globe Newswire
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market ...
10/29/2025 - GuruFocus
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
10/29/2025 - Globe Newswire
DBV Technologies (NASDAQ:DBVT) Posts Quarterly Earnings Results, Beats Expectations By $0.25 EPS
10/29/2025 - MarketBeat
DBV Technologies price target raised by $4 at H.C. Wainwright, here's why
10/29/2025 - The Fly
DBV Technologies (DBVT) to Release Earnings on Wednesday
10/29/2025 - MarketBeat
DBV Technologies Reports Q3 2025 Financial Results
10/29/2025 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
$5.50M
EBITDA (TTM)
-$122.73M
EBIT (TTM)
-$125.87M
Net Income (TTM)
-$125.13M
Balance Sheet
Total Assets (Q)
$110.50M
Total Debt (Q)
$7.69M
Total Liabilities (Q)
$57.64M
Book Value Per Share (Q)
$0.3863
Cash Flow
Cash from Operations (TTM)
-$98.26M
Cash from Investing (TTM)
$139.00K
Cash from Financing (TTM)
$117.80M
Net Change in Cash (TTM)
$23.40M
Filings
Filing Date
Tuesday, October 28, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Apr 6 and 10 (est)
Price History
Loading...
Beta
-1.14
7-Day Total Return
-8.15%
30-Day Total Return
52.51%
60-Day Total Return
42.26%
90-Day Total Return
35.63%
Year to Date Total Return
329.85%
1-Year Total Return
277.98%
2-Year Total Return
42.55%
3-Year Total Return
-6.87%
5-Year Total Return
-35.92%
52-week Low
Nov 19, 2024 - $2.20
52-week High
Oct 16, 2025 - $18.00
Valuation
Market Cap
$495.15M - Small Cap
Enterprise Value
$434.28M
Price/Sales (TTM)
349.25
Price/Book (Q)
36.34
Dividends and Shares
Shares Outstanding
136.81
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.dbv-technologies.com
Phone Number
33 1 55 42 78 78
Address
Bâtiment IRO
Châtillon, 92320
Country
France
Year Founded
2002
Business Description
Sector
--
Industry
--
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. The company’s product pipeline... more
NASDAQ 11/07/2025 4:00PM Eastern Quotes delayed